Efficacy and Safety of a Novel Breath-Powered Powder Sumatriptan Intranasal Treatment for Acute Migraine

Trial Profile

Efficacy and Safety of a Novel Breath-Powered Powder Sumatriptan Intranasal Treatment for Acute Migraine

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2013

At a glance

  • Drugs Sumatriptan (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jul 2013 The primary endpoint of 'Pain-relief' has been met, according to the 2013 International Headache Congress abstract.
    • 12 Jul 2013 New trial record
    • 30 Jun 2013 Results presented at the 2013 International Headache Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top